Stewardship program for restricted use of antimicrobials in the elderly: a cohort study in a quaternary hospital in Brazil
DOI:
https://doi.org/10.30968/rbfhss.2023.143.0936Abstract
Objective: The stewardship strategy refers to a consistent practice to promoting responsible antimicrobial use. Optimizing the use of antibiotics is critical to mitigating adverse effects and combating bacterial resistance. The pillars of a stewardship program include: i) clinical pharmacist and infectologist with expertise; ii) educational measures for prescribers, nurses and pharmacists; iii) prophylaxis and therapeutic protocol; iv) monitoring of indicators. In this scenario of antimicrobial rational use, the older population are more susceptible to infection because immunocenescence and, therefore, greater use of antimicrobials is expected. Thus, the aim of the present study is to evaluate the prescription compliance of antimicrobial whose use is restricted in a hospitalized elderly population. Method: observational, controlled study in a Brazilian hospital, from January 2021 to January 2022. Based on the electrotonic antimicrobial form, the compliance of the prescriptions was evaluated. The definition used for elderly corresponded to individuals over 60 years old, according to the Brazilian Nation Principles for Older Persons, ordinance number 2528, of October 2006. Restricted drugs were considered: carbapenems, polymyxin, ceftazidime-avibactam, linezolid, tigecycline, ceftaroline, echinocandins and amphotericin. Results: A total of 1.688 requests for restricted use were received, of which 53% corresponded use in elderly group. Neutropenic fever was more common in young people and the inpatient unit was the sector with the highest percentage of antimicrobials. Furthermore, teicoplanin was the main drug that required intervention. Conclusion: Faced with the increase in bacterial resistance, the rational use of antimicrobials is extremely important, especially in older age group.
Downloads
References
O’neill, Jim, Book review: Tackling drug-resistant Infections Globally. Arch Pharm Pract, v. 7, n. 3, p. 110, 2016. doi:10.4103/2045-080X.186181
McEwen SA, Collignon PJ. Antimicrobial Resistance: A One Health Perspective. Microbiol Spectr. 2018 Mar;6(2). doi: 10.1128/microbiolspec.ARBA-0009-2017.
Fishman N. Antimicrobial stewardship. Am J Infect Control. 2006 Jun;34(5 Suppl 1):S55-63; discussion S64-73. doi: 10.1016/j.ajic.2006.05.237.
Castro MS, Pilger D, Ferreira MBC, Kopittke L. Tendências na utilização de antimicrobianos em um hospital universitário, 1990-1996. Rev Saúde Pública 2002; 36(5):553-8. doi: 10.1590/S0034-89102002000600003.
Ministério da Saúde. TabNet Win32 3.0: Projeção da População do Brasil por sexo e idade simples: 2000-2060, Datasus. gov.br, disponível em: <http://tabnet.datasus.gov.br/cgi/tabcgi.exe?ibge/cnv/projpopbr.def>. acesso em: 23 set. 2022.
Mendelson M, Morris AM, Thursky K, et.al. How to start an antimicrobial stewardship programme in a hospital. Clin Microbiol Infect. 2020 Apr;26(4):447-453. doi: 10.1016/j.cmi.2019.08.007.
Anvisa. Agência Nacional de Vigilância Sanitária. Gerência Geral de Tecnologia em Serviços de Saúde. Gerência de Vigilância e Monitoramento em Serviços de Saúde. Avaliação Nacional dos Programas de Gerenciamento do Uso de Antimicrobianos em Unidade de Terapia Intensiva Adulto dos Hospitais Brasileiros. Brasil. 2019.
World Health Organization. WHO Access, Watch, Reserve (AWaRe) classification of antibiotics for evaluation and monitoring of use, 2021. Geneva: World Health Organization; 2021 (WHO/MHP/HPS/EML/2021.04).
World Health Organization (WHO) (2002) Active Ageing – A Police Framework. A Contribution of the World Health Organization to the second United Nations World Assembly on Aging. Madrid, Spain, April, 2002.).
Voumard R, Rubli Truchard E, Benaroyo L, et.al. Geriatric palliative care: a view of its concept, challenges, and strategies. BMC Geriatr. 2018 Sep 20;18(1):220. doi: 10.1186/s12877-018-0914-0.
Zahar JR, Ghaffari P, Kamga I, et.al. Audit des prescriptions antibiotiques dans un service de maladies infectieuses. A prospective and observational survey [Audit on antibiotic prescriptions in a department of infectious diseases]. Presse Med. 2003 Aug 9;32(26):1208-12.
Tünger O, Dinç G, Ozbakkaloglu B, et.al. Evaluation of rational antibiotic use. Int J Antimicrob Agents. 2000 Jul;15(2):131-5. doi: 10.1016/s0924-8579(00)00158-8.
Kingren MS, Starr ME, Saito H. Divergent Sepsis Pathophysiology in Older Adults. Antioxid Redox Signal. 2021 Dec;35(16):1358-1375. doi: 10.1089/ars.2021.0056.
Daneman N, Gruneir A, Bronskill SE, et.al. Prolonged antibiotic treatment in long-term care: role of the prescriber. JAMA Intern Med. 2013 Apr 22;173(8):673-82. doi: 10.1001/jamainternmed.2013.3029.
Empresa Brasileira de Serviços Hospitalares. Manual de Boas Práticas na Prescrição de Antimicrobiano. Disponível em: https://www.gov.br/ebserh/pt-br/hospitais-universitarios/regiao-sudeste/hc-uftm/documentos/manuais/copy_of__ManualdeBoasPrticasnaPrescriodeAntimicrobianos_v3final.pdf acesso em 02 de janeiro de 2023.
da Silva NCZ, da Rocha JA, do Valle FM, et.al. The impact of ageing on the incidence and mortality rate of bloodstream infection: A hospital-based case-cohort study in a tertiary public hospital of Brazil. Trop Med Int Health. 2021 Oct;26(10):1276-1284. doi: 10.1111/tmi.13650.
Schuts EC, Hulscher MEJL, Mouton JW, et.al. Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis. Lancet Infect Dis. 2016 Jul;16(7):847-856. doi: 10.1016/S1473-3099(16)00065-
Epub 2016 Mar 3. Erratum in: Lancet Infect Dis. 2016 Jul;16(7):768.
Takamatsu A, Yao K, Murakami S,et.al. Barriers to Adherence to Antimicrobial Stewardship Postprescription Review and Feedback For Broad-Spectrum Antimicrobial Agents: A Nested Case-Control Study. Open Forum Infect Dis. 2020 Jul 17;7(8):ofaa298. doi: 10.1093/ofid/ofaa298.
. Wee LE, Chung SJ, Tang SLS, et.al. Who listens and who doesn’t? Factors associated with adherence to antibiotic stewardship intervention in a Singaporean tertiary hospital. J Glob Antimicrob Resist. 2020 Sep;22:391-397. doi: 10.1016/j.jgar.2020.04.006.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The authors hereby transfer, assign, or otherwise convey to RBFHSS: (1) the right to grant permission to republish or reprint the stated material, in whole or in part, without a fee; (2) the right to print republish copies for free distribution or sale; and (3) the right to republish the stated material in any format (electronic or printed). In addition, the undersigned affirms that the article described above has not previously been published, in whole or part, is not subject to copyright or other rights except by the author(s), and has not been submitted for publication elsewhere, except as communicated in writing to RHFHSS with this document.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY-NC-ND) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Serlf-archiving policy
This journal permits and encourages authors to post and archive the final pdf of the articles submitted to the journal on personal websites or institutional repositories after publication, while providing bibliographic details that credit its publication in this journal.